McElhiney Martin C, Rabkin Judith G, Rabkin Richard, Nunes Edward V
Therapeutics, New York State Psychiatric Institute, New York, New York, USA.
Am J Drug Alcohol Abuse. 2009;35(1):34-7. doi: 10.1080/00952990802342907.
To evaluate the efficacy of modafinil combined with cognitive behavioral therapy (CBT) for treatment of methamphetamine (MA) dependence among HIV+ gay men.
In a single blind trial, modafinil was administered for 12 weeks, followed by a 4-week placebo phase. CBT was conducted for 18 sessions over the 16-week study. Primary outcome measures were self-reported use of days per week plus urine toxicology assays. Additional measures included the Beck Depression Inventory, Cravings Scale, and O/C Crystal Use Scale. Response was defined as > 50% decline in days used per week. Thirteen patients were enrolled over an 18-month period.
Ten patients (77%) completed the trial, although two discontinued modafinil due to side effects. Six of the ten study completers reduced their MA use by > 50%.
These preliminary results suggest good retention using combined medication and psychotherapy, and support further examination of modafinil and CBT in double-blind placebo controlled trials.
评估莫达非尼联合认知行为疗法(CBT)治疗HIV阳性男同性恋者甲基苯丙胺(MA)依赖的疗效。
在一项单盲试验中,莫达非尼给药12周,随后是4周的安慰剂阶段。在为期16周的研究中进行了18次CBT治疗。主要结局指标是自我报告的每周使用天数以及尿液毒理学检测。其他指标包括贝克抑郁量表、渴望量表和O/C晶体使用量表。反应定义为每周使用天数下降>50%。在18个月的时间里招募了13名患者。
10名患者(77%)完成了试验,尽管有两名患者因副作用停止使用莫达非尼。10名完成研究的患者中有6名将其MA使用量减少了>50%。
这些初步结果表明联合药物治疗和心理治疗具有良好的保留率,并支持在双盲安慰剂对照试验中进一步研究莫达非尼和CBT。